Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab

類似資料

• Peripheral CD8 effector memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
  著者:: Wistuba-Hamprecht, Kilian, 等
  出版事項: (2017)
• Increases in Absolute Lymphocytes and Circulating CD4(+) and CD8(+) T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
  著者:: Martens, Alexander, 等
  出版事項: (2016)
• Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab
  著者:: Martens, Alexander, 等
  出版事項: (2016)
• Peripheral blood T-cell signatures from high-resolution immune phenotyping of γδ and αβ T-cells in younger and older subjects in the Berlin Aging Study II
  著者:: Wistuba-Hamprecht, Kilian, 等
  出版事項: (2015)
• Genetic Influence on the Peripheral Differentiation Signature of Vδ2+ γδ and CD4+ αβ T Cells in Adults
  著者:: Beucke, Nicola, 等
  出版事項: (2021)